Daiana Stolz
Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial.
Darie A, Khanna N, Jahn K, Osthoff M, Bassetti S, Osthoff M, Schumann D, Albrich W, Hirsch H, Brutsche M, Grize L, Tamm M, Stolz D. Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir Med 2022; 10:877-887.
23.05.2022Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial.
23.05.2022Lancet Respir Med 2022; 10:877-887
Darie Andrei M, Khanna Nina, Jahn Kathleen, Osthoff Michael, Bassetti Stefano, Osthoff Mirjam, Schumann Desiree M, Albrich Werner, Hirsch Hans, Brutsche Martin, Grize Leticia, Tamm Michael, Stolz Daiana
Laryngopharyngeal reflux in chronic obstructive pulmonary disease - a multi-centre study
Sanchez J, Schumann D, Karakioulaki M, Papakonstantinou E, Rassouli F, Frasnelli M, Brutsche M, Tamm M, Stolz D. Laryngopharyngeal reflux in chronic obstructive pulmonary disease - a multi-centre study. Respir Res 2020; 21:220.
21.08.2020Laryngopharyngeal reflux in chronic obstructive pulmonary disease - a multi-centre study
21.08.2020Respir Res 2020; 21:220
Sanchez Julia, Schumann Desiree M, Karakioulaki Meropi, Papakonstantinou Eleni, Rassouli Frank, Frasnelli Matthias, Brutsche Martin, Tamm Michael, Stolz Daiana
Serum levels of hyaluronic acid are associated with COPD severity and predict survival
Papakonstantinou E, Welte T, Torres A, Lacoma A, Rohde G, Aerts J, Blasi F, Kostikas K, Stieltjes B, Boersma W, Milenkovic B, Louis R, Baty F, Schumann D, Tamm M, Roth M, Bonovolias I, Stolz D. Serum levels of hyaluronic acid are associated with COPD severity and predict survival. Eur Respir J. 2019; 53
07.03.2019Serum levels of hyaluronic acid are associated with COPD severity and predict survival
07.03.2019Eur Respir J. 2019; 53
Papakonstantinou Eleni, Welte Tobias, Torres Antoni, Lacoma Alicia, Rohde Gernot G U, Aerts Joachim G, Blasi Francesco, Kostikas Konstantinos, Stieltjes Bram, Boersma Wim, Milenkovic Branislava, Louis Renaud, Baty Florent, Schumann Desiree, Tamm Michael, Roth Michael, Bonovolias Ioannis, Stolz Daiana
Diagnosis, Prevention and Treatment of Stable COPD and Acute Exacerbations of COPD: The Swiss Recommendations 2018
Stolz D, Latshang T, Lechmann A, Maurer M, Nicod L, Quadri F, Schilter D, Sigrist T, Soccal P, Tarr P, Thurnheer R, Turk A, Kohler M, Junker L, Helfenstein E, Barandun J, Borer H, Bridevaux P, Brun P, Brutsche M, Clarenbach C, Eich C, Fiechter R, Frey M, Geiser T, Grob M, Tamm M. Diagnosis, Prevention and Treatment of Stable COPD and Acute Exacerbations of COPD: The Swiss Recommendations 2018. Respiration 2018; 96:382-398.
23.08.2018Diagnosis, Prevention and Treatment of Stable COPD and Acute Exacerbations of COPD: The Swiss Recommendations 2018
23.08.2018Respiration 2018; 96:382-398
Stolz Daiana, Latshang Tsogyal, Lechmann Armin, Maurer Marc, Nicod Laurent, Quadri Franco, Schilter Daniel, Sigrist Thomas, Soccal Paola, Tarr Philip, Thurnheer Robert, Turk Alexander, Kohler Malcolm, Junker Lilian, Helfenstein Erich, Barandun Jürg, Borer Heinz, Bridevaux Pierre-Olivier, Brun Patrick, Brutsche Martin, Clarenbach Christian, Eich Christine, Fiechter René, Frey Martin, Geiser Thomas, Grob Michael, Tamm Michael
Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk
Rassouli F, Baty F, Stolz D, Albrich W, Tamm M, Widmer S, Brutsche M. Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk. Int J Chron Obstruct Pulmon Dis 2017; 12:3103-3109.
24.10.2017Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk
24.10.2017Int J Chron Obstruct Pulmon Dis 2017; 12:3103-3109
Rassouli Frank, Baty Florent, Stolz Daiana, Albrich Werner, Tamm Michael, Widmer Sandra, Brutsche Martin
Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD Audit
Buess M, Fiechter R, Sigrist T, Brun P, Barandun J, Koltai E, López-Campos J, Hartl S, Roberts M, Schumann D, Tamm M, Solèr M, Helfenstein E, Geiser T, Schilter D, Schneider T, Maurer M, Borer H, Thurnheer R, Köhler E, Junker L, Jahn K, Grob M, Rüdiger J, Stolz D. Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD Audit. Respiration 2017; 94:355-365.
19.07.2017Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD Audit
19.07.2017Respiration 2017; 94:355-365
Buess Michael, Fiechter René, Sigrist Thomas, Brun Patrick, Barandun Jürg, Koltai Eva, López-Campos José Luis, Hartl Sylvia, Roberts Michael, Schumann Desiree M, Tamm Michael, Solèr Markus, Helfenstein Erich, Geiser Thomas, Schilter Daniel, Schneider Tino, Maurer Marc, Borer Heinz, Thurnheer Robert, Köhler Erich, Junker Lilian, Jahn Kathleen, Grob Michael, Rüdiger Jochen, Stolz Daiana
Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study
Salomon J, Clemens A, Kostikas K, Wild C, Geiser T, Schmidt U, Fitting J, Sigrist T, Azzola A, Turk A, Frey J, Domenighetti G, Stolz D, Brutsche M. Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study. Respir Res 2017; 18:13.
11.01.2017Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study
11.01.2017Respir Res 2017; 18:13
Salomon Joerg, Clemens Andreas, Kostikas Konstantinos, Wild Corinne, Geiser Thomas, Schmidt Ulrich, Fitting Jean-William, Sigrist Thomas, Azzola Andrea, Turk Alexander J, Frey Jean-Georges, Domenighetti Guido, Stolz Daiana, Brutsche Martin
Sedative drug requirements during flexible bronchoscopy
Chhajed P, Wallner J, Stolz D, Baty F, Strobel W, Brutsche M, Tamm M. Sedative drug requirements during flexible bronchoscopy. Respiration; international review of thoracic diseases 2005; 72:617-21.
01.12.2005Sedative drug requirements during flexible bronchoscopy
01.12.2005Respiration; international review of thoracic diseases 2005; 72:617-21
Chhajed Prashant N, Wallner Julia, Stolz Daiana, Baty Florent, Strobel Werner, Brutsche Martin, Tamm Michael
Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept
Leuppi J, Chan H, Greiff L, Andersson M, Knoblauch A, Surber C, Perruchoud A, Bingisser R, Brutsche M, Stolz D, Anderson S, Tandjung R, Tamm M. Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept. Pulmonary pharmacology & therapeutics 2005; 18:83-8.
01.01.2005Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept
01.01.2005Pulmonary pharmacology & therapeutics 2005; 18:83-8
Leuppi Jörg D, Chan Hak-Kim, Greiff Lennart, Andersson Morgan, Knoblauch Andreas, Surber Christian, Perruchoud André P, Bingisser Roland, Brutsche Martin, Stolz Daiana, Anderson Sandra D, Tandjung Ryan, Tamm Michael